What is RMD's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 33.55B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for RMD?

P/E (TTM) is 20.77 and 52-week range is $180.26 to $277.67 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s RMD figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for RMD?

The company profile lists revenue (TTM) near $5.62B, net income (TTM) near $1.56B, EPS (TTM) near $10.98 when available from the market-data feed. Figures are informational and may lag live markets.

Does RMD show a dividend on Chartloom?

The overview lists dividend per share (TTM) near $2.49, yield near 1.08%, ex-dividend date Nov 12, 2026 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is ResMed Inc. based, and what identifiers does Chartloom list?

The company context section lists headquarters in San Diego, California, US, 140.7M shares outstanding, ISIN US7611521078 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

ResMed Inc.

$RMD

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 11,370 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

Employees

11,370

Website

www.resmed.com/

IPO

1995-06-01

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NEW YORK STOCK EXCHANGE, INC.

ISIN

US7611521078

Headquarters

San Diego, California, US

Shares outstanding

140.7M

NAICS sector

Manufacturing

Institutional ownership

71.43%

Browse other companiesFree AI scores and summaries for more stocks